Research suggests a link between weight gain and breast cancer risk, highlighting the importance of managing weight after a breast cancer diagnosis. Some studies indicate that certain weight-loss drugs, including GLP-1s, may help reduce breast cancer risk, although the relationship between these drugs and breast cancer care is still being explored. The potential benefits and implications of using these drugs in breast cancer treatment are being investigated in ongoing research and upcoming clinical trials.